In the Vinony graph
گیلیاد is indexed among the 527 entries in Vinony's S&P 500 Companies collection.
Within Vinony's link graph, گیلیاد is referenced by 1,030 other articles, and connects out to tenofovir alafenamide, tenofovir disoproxil and HIV/AIDS.
It sits within the topics 1987 establishments in California, 1992 initial public offerings and American companies established in 1987.
Its subject is documented across 30 Wikipedia language editions.
Key facts
- Company type
- Public
- Traded as
- Nasdaq : GILD Nasdaq-100 component S&P 100 component S&P 500 component
- Industry
- Pharmaceutics Biotechnology
- Founded
- June 22, 1987 ; 38 years ago ( 1987-06-22 )
- Founder
- Michael L. Riordan
- Headquarters
- Foster City, California , United States
- Area served
- Worldwide
- Key people
- Daniel O'Day ( chairman and CEO ) Andrew Dickinson ( CFO ) Tomáš Cihlář ( vice president , and senior director, Biology)
- Products
- AmBisome Atripla Biktarvy Complera Cayston Descovy Emtriva Epclusa Genvoya Harvoni Hepcludex Hepsera Letairis Lexiscan Livdelzi Macugen Odefsey Ranexa Sovaldi Stribild Sunlenca Tamiflu Truvada Tybost Veklury Vemlidy Viread Vosevi Yescarta Yeztugo Zydelig
- Revenue
- US$ 29.44 billion (2025)
- Operating income
- US$10.02 billion (2025)
- Net income
- US$8.510 billion (2025)
- Total assets
- US$59.02 billion (2025)
- Total equity
- US$22.70 billion (2025)
- Number of employees
- 17,000 (2025)
- Website
- gilead .com
via Wikipedia infobox
Company
GILD- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- DE
- Entity type
- operating
- Jurisdiction
- US-DE
- Headquarters
- WILMINGTON, US
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1987
- Location
- Foster City, United States
- Status
- Active
GRID grid.418227.a · ISNI 0000 0004 0402 1634
Wikidata facts
- Instance of
- pharmaceutical company
- Part of
- S&P 100
- Official name
- Gilead Sciences, Inc.
- Country
- United States
- Headquarters
- Foster City
- Owned by
- The Vanguard Group
- Industry
- pharmaceutical industry
- Employees
- 11800
- Revenue
- 27281000000
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- www.gilead.com
- Image
- 333 Lakeside Drive.jpg
Show 9 more facts
- topic's main category
- Category:Gilead Sciences
- Commons category
- Gilead Sciences
- inception
- 1987-06-00
- total assets
- 61627000000
- net profit
- 4592000000
- market capitalization
- 66400000000
- total equity
- 19113000000
- operating income
- 7330000000
- social media followers
- 5890
Sources (13)
via Wikidata · CC0
Connections
tenofovir alafenamide
Entity
tenofovir disoproxil
Entity
HIV/AIDS
Entity
Nasdaq
Entity
remdesivir
Entity
oseltamivir
Entity
Bristol-Myers Squibb
Entity
emtricitabine
Entity
prostacyclin
Entity
sofosbuvir
Entity
cidofovir
Entity
adefovir
Entity
sacituzumab govitecan
Entity
Allergan plc
Entity
ledipasvir/sofosbuvir
Medication
Alnylam Pharmaceuticals
Company
Endo International plc
Company
George W. Bush
Person
COVID-19
Entity
Oregon
Entity
Categories
1987 establishments in California1992 initial public offeringsAmerican companies established in 1987Biotechnology companies established in 1987Biotechnology companies of the United StatesCompanies associated with the COVID-19 pandemicCompanies based in Foster City, CaliforniaCompanies in the Nasdaq-100Companies listed on the NasdaqGilead SciencesLife sciences industryPharmaceutical companiesPharmaceutical companies established in 1987Specialty drugs